Company Filing History:
1 out of 3,923 
1 out of 52 
Years Active: 2015
Title: Giuseppe Del Guidice: Innovator in Mucosal Vaccine Development
Introduction
Giuseppe Del Guidice is a notable inventor based in Siena, Italy. He has made significant contributions to the field of immunology, particularly in the development of mucosal vaccines. His innovative approach combines advanced adjuvants with specific antigens to enhance vaccine efficacy.
Latest Patents
Del Guidice holds a patent for "Mucosal vaccines with chitosan adjuvant and meningococcal antigens." This invention provides immunogenic compositions that include a capsular saccharide antigen from serogroup C and a chitosan adjuvant. The composition is designed for mucosal delivery, including intranasal administration. Additionally, it encompasses further antigens and adjuvants, making it versatile for various applications. The patent highlights the use of conjugated oligosaccharide antigens, which are particularly preferred for their effectiveness.
Career Highlights
Throughout his career, Giuseppe Del Guidice has worked with prominent organizations, including Novartis AG and Universiteit Leiden. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in vaccine development.
Collaborations
One of his notable collaborators is Barbara Baudner, with whom he has worked on various projects related to immunogenic compositions. Their partnership has furthered the understanding and application of mucosal vaccines.
Conclusion
Giuseppe Del Guidice's work in the field of mucosal vaccines represents a significant advancement in immunology. His innovative patent and collaborations with esteemed organizations highlight his commitment to improving vaccine delivery and efficacy.